Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Mammography for symptomless women--not so wise?

Cutler WB, Burki RE, Kolter J, Chambliss C.

Climacteric. 2013 Jun;16(3):313-5. doi: 10.3109/13697137.2013.771463. Epub 2013 Feb 20. Review.

PMID:
23425505
[PubMed - indexed for MEDLINE]
2.

Effect of three decades of screening mammography on breast-cancer incidence.

Bleyer A, Welch HG.

N Engl J Med. 2012 Nov 22;367(21):1998-2005. doi: 10.1056/NEJMoa1206809.

PMID:
23171096
[PubMed - indexed for MEDLINE]
Free Article
3.

Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.

PMID:
23074501
[PubMed]
Free PMC Article
4.

Evaluating organized breast cancer screening implementation: the prevention of late-stage disease?

Taplin SH, Ichikawa L, Buist DS, Seger D, White E.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):225-34.

PMID:
14973097
[PubMed - indexed for MEDLINE]
Free Article
6.

Trends in breast cancer by race and ethnicity: update 2006.

Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M.

CA Cancer J Clin. 2006 May-Jun;56(3):168-83.

PMID:
16737949
[PubMed - indexed for MEDLINE]
7.

Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.

Coldman A, Phillips N.

CMAJ. 2013 Jul 9;185(10):E492-8. doi: 10.1503/cmaj.121791. Epub 2013 Jun 10.

PMID:
23754101
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.

Schousboe JT, Kerlikowske K, Loh A, Cummings SR.

Ann Intern Med. 2011 Jul 5;155(1):10-20. doi: 10.7326/0003-4819-155-1-201107050-00003.

PMID:
21727289
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Responding to the challenges of breast cancer in egypt and other arab countries.

El Saghir NS.

J Egypt Natl Canc Inst. 2008 Dec;20(4):309-12.

PMID:
20571588
[PubMed - in process]
Free Article
10.

Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).

Anderson WF, Jatoi I, Devesa SS.

Breast Cancer Res Treat. 2006 Oct;99(3):333-40. Epub 2006 May 9.

PMID:
16703451
[PubMed - indexed for MEDLINE]
11.

Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.

Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2013 May 13;173(9):807-16. doi: 10.1001/jamainternmed.2013.307.

PMID:
23552817
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Secular trends in the incidence of female breast cancer in the United States, 1973-1998.

Nasseri K.

Breast J. 2004 Mar-Apr;10(2):129-35. Erratum in: Breast J. 2004 Jul-Aug;10(4):380.

PMID:
15009040
[PubMed - indexed for MEDLINE]
13.

Trends in breast cancer by race and ethnicity.

Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M.

CA Cancer J Clin. 2003 Nov-Dec;53(6):342-55. Erratum in: CA Cancer J Clin. 2004 May-Jun;54(3):181.

PMID:
15224974
[PubMed - indexed for MEDLINE]
14.
15.

Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence.

Buist DS, Walker R, Bowles EJ, Carney PA, Taplin SH, Onega T, Kerlikowske K, Clinton W, Miglioretti DL.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):720-7. doi: 10.1158/1055-9965.EPI-11-1115. Epub 2012 Feb 1.

PMID:
22301831
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

Glass AG, Lacey JV Jr, Carreon JD, Hoover RN.

J Natl Cancer Inst. 2007 Aug 1;99(15):1152-61. Epub 2007 Jul 24.

PMID:
17652280
[PubMed - indexed for MEDLINE]
Free Article
17.

How do I screen patients for breast cancer?

Krontiras H, Bramlett R, Umphrey H.

Curr Treat Options Oncol. 2013 Mar;14(1):88-96. doi: 10.1007/s11864-012-0218-0.

PMID:
23315271
[PubMed - indexed for MEDLINE]
18.

[Early results of breast cancer screening research].

Nowicki A, Stogowska I.

Ginekol Pol. 2007 Jun;78(6):464-70. Polish.

PMID:
17899703
[PubMed - indexed for MEDLINE]
19.

Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?

Taplin SH, Ichikawa L, Yood MU, Manos MM, Geiger AM, Weinmann S, Gilbert J, Mouchawar J, Leyden WA, Altaras R, Beverly RK, Casso D, Westbrook EO, Bischoff K, Zapka JG, Barlow WE.

J Natl Cancer Inst. 2004 Oct 20;96(20):1518-27.

PMID:
15494602
[PubMed - indexed for MEDLINE]
Free Article
20.

Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program.

Hofvind S, Lee CI, Elmore JG.

Breast Cancer Res Treat. 2012 Aug;135(1):291-9. doi: 10.1007/s10549-012-2162-x. Epub 2012 Jul 26.

PMID:
22833199
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk